Published: 5 September 2019
Publications
Quarterly summary of recent safety communications
Prescriber Update 40(3): 58
September 2019
The table below is a summary of recent safety communications to healthcare professionals and consumers, published on the Medsafe website.
Date | Communication | Topic |
---|---|---|
16 August 2019 | Monitoring Communication | Cathejell Lignocaine 2% Gel and reports of issues when using this medicine |
9 August 2019 | Monitoring Communication | Tramadol and opioid effects in breastfeeding babies – monitoring extended to 30 November 2019 |
9 August 2019 | Dear Healthcare Professional Letter | Femme-Tab (PDF 174 KB, 1 page) – brought in to cover stock shortage of combined oral contraceptive products (Microgynon, Levlen); information about blister pack differences |
1 August 2019 | Alert Communication | Medsafe is issuing a warning to consumers to stop taking Go lean Detox and Go Detox - statement under section 98 of the Medicines Act 1981 |
31 July 2019 | Monitoring Communication | Update – Breast implants and anaplastic large cell lymphoma |
17 July 2019 | Dear Healthcare Professional Letter | Ranbaxy-Cefaclor (PDF 222KB, 1 page) - Supply disruption for Cefaclor oral suspension and Acarbose tablets: difference in reconstitution volume for Keflor granules |
3 July 2019 | Dear Healthcare Professional Letter | FluQuadri (PDF 109 KB, 2 pages) – Additional supply of FluQuadri influenza vaccine: differences in labelling and package inserts |
28 June 2019 | Publications | Consumer Information Leaflet – Taking Lithium during pregnancy (PDF 319 KB, 2 pages) |
11 June 2019 | Dear Healthcare Professional Letter | Xiaflex® (collagenase clostridium histolyticum) product discontinuation from 28 June 2019 (PDF 231 KB, 2 pages) |